KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Other financing activities (2019 - 2025)

Historic Other financing activities for Vir Biotechnology (VIR) over the last 5 years, with Q3 2025 value amounting to $1000.0.

  • Vir Biotechnology's Other financing activities rose 10250.0% to $1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$164000.0, marking a year-over-year increase of 7097.35%. This contributed to the annual value of -$165000.0 for FY2024, which is 4250.87% up from last year.
  • Per Vir Biotechnology's latest filing, its Other financing activities stood at $1000.0 for Q3 2025, which was up 10250.0% from $13000.0 recorded in Q4 2024.
  • In the past 5 years, Vir Biotechnology's Other financing activities registered a high of $100000.0 during Q1 2023, and its lowest value of -$387000.0 during Q4 2023.
  • Its 4-year average for Other financing activities is -$101571.4, with a median of -$40000.0 in 2024.
  • Its Other financing activities has fluctuated over the past 5 years, first crashed by 4884.62% in 2023, then skyrocketed by 10335.92% in 2024.
  • Vir Biotechnology's Other financing activities (Quarter) stood at -$260000.0 in 2022, then crashed by 48.85% to -$387000.0 in 2023, then skyrocketed by 103.36% to $13000.0 in 2024, then crashed by 92.31% to $1000.0 in 2025.
  • Its Other financing activities stands at $1000.0 for Q3 2025, versus $13000.0 for Q4 2024 and -$40000.0 for Q3 2024.